Buprenorphine/Naloxone Sublingual Film (TAHO Pharmaceuticals)

N/A

Report date: 2025/12/12 17:32:30

Base Information

Drug NameBuprenorphine/Naloxone Sublingual Film (TAHO Pharmaceuticals)
Drug Alias NameTAH2211TAH-2211
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionKappa opioid receptor antagonistsOpioid receptors antagonistsMu opioid receptor agonists
TargetsKappa opioid receptorOpioid receptorsMu opioid receptor
Therapy Area/IndicationsOpioid-Related Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsYes
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTAHO Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTAHO Pharmaceuticals Ltd
Inactive CompaniesN/A
Active IndicationsOpioid-Related Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A